Metropolitan Digital

Google


.

The FDA's rule change requiring providers to inform women about breast density could lead to a flurry of questions

  • Written by Wendie A. Berg, Professor of Radiology, School of Medicine, University of Pittsburgh
The FDA's rule change requiring providers to inform women about breast density could lead to a flurry of questionsBreast density is one of the factors that can influence whether people should pursue supplemental screening. andresr/E+ via Getty Images

The U.S. Food and Drug Administration finalized a regulation in early March 2023 that updates mammography reporting requirements. The new regulation goes into effect on Sept. 10, 2024, and will require that all...

Read more: The FDA's rule change requiring providers to inform women about breast density could lead to a...